GSK beats Q3 profit estimates on specialty medicines strength
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- GSK PLC reported third-quarter results that exceeded analyst expectations, with adjusted earnings per share of 54.6 pence compared to the consensus estimate of 50.4 pence. Still guessing which stocks will beat the market? Our AI portfolio updates monthly and is…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishEarnings above expectations are a positive factor for a large pharmaceutical stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Adjusted EPS was 54.6 pence versus a 50.4 pence consensus.
- 02Revenue rose 5% at constant exchange rates to £8.89 billion.
- 03Specialty Medicines sales grew 15% to £3.9 billion.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets